UAB "Molekulės" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 239,414 |
| 37,467 |
| 4,647 |
| 4,415 |
| 691 |
| 53.80 |
| 1.84 |
| 34,470 |
| 19,824 |
| 9,934 |
| 44,360 |
| 2023 |
|---|
| 229,076 |
| 34,344 |
| 11,803 |
| 11,105 |
| 1,665 |
| 58.42 |
| 4.85 |
| 40,412 |
| 20,579 |
| 7,691 |
| 53,300 |
| 2024 |
|---|
| 241,137 |
| 39,857 |
| 12,405 |
| 11,785 |
| 1,948 |
| 53.86 |
| 4.89 |
| 52,197 |
| 19,816 |
| 12,157 |
| 59,856 |
Register and
explore Okredo data| 2024 |
|---|
| 241,137 |
| 39,857 |
| 12,405 |
| 11,785 |
| 1,948 |
| 53.86 |
| 4.89 |
| 52,197 |
| 19,816 |
| 12,157 |
| 59,856 |
Register and
explore Okredo data2024
Turnover (€)
241,137 €
5 % *
Sales per employee (€)
39,857 €16 % *
Profit before tax (€)
12,405 €5 % *
Net Profit (€)
11,785 €6 % *
Profit per employee (€)
1,948 €17 % *
Total profitability (%)
53.86 %
-7.81 % *
Net profitability (%)
4.89 %0.82 % *
Equity (€)
52,197 €29 % *
Amounts Payable And Liabilities (€)
19,816 €
-4 % *
Non-current Assets (€)
12,157 €
58 % *
CurrentAssets (€)
59,856 €12 % *